{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T19:45:17Z","timestamp":1782589517440,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["RS-2025-02215878"],"award-info":[{"award-number":["RS-2025-02215878"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002631","name":"Gachon University","doi-asserted-by":"publisher","award":["2023.(GCU-202401050001)"],"award-info":[{"award-number":["2023.(GCU-202401050001)"]}],"id":[{"id":"10.13039\/501100002631","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"DOI":"10.1007\/s13346-026-02175-w","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T18:53:03Z","timestamp":1782586383000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Redispersible nanoalum-adjuvanted hepatitis B vaccine microneedles with enhanced immunogenicity"],"prefix":"10.1007","author":[{"given":"Miju","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyemi","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seojin","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Ju","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ki","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaiwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Myun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kihyuck","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4684-7568","authenticated-orcid":false,"given":"Jung-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"2175_CR1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/21645515.2014.1004026","volume":"11","author":"P He","year":"2015","unstructured":"He P, Zou Y, Hu Z. Advances in aluminum hydroxide-based adjuvant research and its mechanism. Hum vaccines immunotherapeutics. 2015;11:477\u201388.","journal-title":"Hum vaccines immunotherapeutics"},{"key":"2175_CR2","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","volume":"20","author":"B Pulendran","year":"2021","unstructured":"Pulendran B, Arunachalam PS, O\u2019Hagan DT. Emerging concepts in the science of vaccine adjuvants. Nat Rev Drug Discovery. 2021;20:454\u201375.","journal-title":"Nat Rev Drug Discovery"},{"key":"2175_CR3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fimmu.2012.00406","volume":"3","author":"H HogenEsch","year":"2013","unstructured":"HogenEsch H. Mechanism of immunopotentiation and safety of aluminum adjuvants. Front Immunol. 2013;3:406.","journal-title":"Front Immunol"},{"key":"2175_CR4","doi-asserted-by":"publisher","first-page":"e2025074874","DOI":"10.1542\/peds.2025-074874","volume":"157","author":"E Nirenberg","year":"2026","unstructured":"Nirenberg E, Maldonado YA, Hoffman SA. The role and safety of aluminum adjuvants in childhood vaccines. Pediatrics. 2026;157:e2025074874.","journal-title":"Pediatrics"},{"key":"2175_CR5","doi-asserted-by":"crossref","unstructured":"Perez DC, Hernandez-Franco JF, HogenEsch H. Aluminum adjuvants differentially induce IL-1\u03b2 release in vitro yet share NLRP3 inflammasome-independent adjuvant effects in vivo. Scientific Reports; 2026.","DOI":"10.1038\/s41598-025-34660-6"},{"key":"2175_CR6","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fimmu.2013.00114","volume":"4","author":"S Awate","year":"2013","unstructured":"Awate S, Babiuk LA, Mutwiri G. Mechanisms of action of adjuvants. Front Immunol. 2013;4:114.","journal-title":"Front Immunol"},{"key":"2175_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","volume":"8","author":"T Zhao","year":"2023","unstructured":"Zhao T, Cai Y, Jiang Y, He X, Wei Y, Yu Y, Tian X. Vaccine adjuvants: mechanisms and platforms. Signal Transduct Target therapy. 2023;8:283.","journal-title":"Signal Transduct Target therapy"},{"key":"2175_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jconrel.2013.10.032","volume":"173","author":"X Li","year":"2014","unstructured":"Li X, Aldayel AM, Cui Z. Aluminum hydroxide nanoparticles show a stronger vaccine adjuvant activity than traditional aluminum hydroxide microparticles. J Controlled Release. 2014;173:148\u201357.","journal-title":"J Controlled Release"},{"key":"2175_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-018-0094-0","volume":"4","author":"MT Orr","year":"2019","unstructured":"Orr MT, Khandhar AP, Seydoux E, Liang H, Gage E, Mikasa T, Beebe EL, Rintala ND, Persson KH, Ahniyaz A. Reprogramming the adjuvant properties of aluminum oxyhydroxide with nanoparticle technology. npj Vaccines. 2019;4:1.","journal-title":"npj Vaccines"},{"key":"2175_CR10","doi-asserted-by":"publisher","first-page":"2060667","DOI":"10.1080\/21645515.2022.2060667","volume":"18","author":"Y Lu","year":"2022","unstructured":"Lu Y, Liu G. Nano alum: A new solution to the new challenge. Hum Vaccines Immunotherapeutics. 2022;18:2060667.","journal-title":"Hum Vaccines Immunotherapeutics"},{"key":"2175_CR11","doi-asserted-by":"publisher","first-page":"94907642","DOI":"10.26599\/NR.2025.94907642","volume":"18","author":"Z Guo","year":"2025","unstructured":"Guo Z, Wei Y, Zhao L. NanoAlum based delivery system to formulate in-situ vaccine for personalized breast cancer immunotherapy. Nano Res. 2025;18:94907642.","journal-title":"Nano Res"},{"key":"2175_CR12","doi-asserted-by":"crossref","unstructured":"Mardliyati E, Syaifie PH, Muttaqien SE, Setyawati DR. Nanoscale alum-based adjuvants: Current status and future prospects, Materials Today: Proceedings, (2024).","DOI":"10.1016\/j.matpr.2024.04.006"},{"key":"2175_CR13","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1039\/C9NR09936K","volume":"12","author":"AP Khandhar","year":"2020","unstructured":"Khandhar AP, Liang H, Simpson AC, Reed SG, Carter D, Fox CB, Orr MT. Physicochemical structure of a polyacrylic acid stabilized nanoparticle alum (nanoalum) adjuvant governs TH1 differentiation of CD4\u2009+\u2009T cells. Nanoscale. 2020;12:2515\u201323.","journal-title":"Nanoscale"},{"key":"2175_CR14","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1016\/j.vaccine.2016.04.081","volume":"34","author":"TB Ruwona","year":"2016","unstructured":"Ruwona TB, Xu H, Li X, Taylor AN, Shi Y-c, Cui Z. Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles. Vaccine. 2016;34:3059\u201367.","journal-title":"Vaccine"},{"key":"2175_CR15","doi-asserted-by":"crossref","unstructured":"Bajoria S, Kumru OS, Doering J, Berman K, Slyke GV, Prigodich A, Rodriguez-Aponte SA, Kleanthous H, Love JC, Mantis NJ. Nanoalum Formulations Containing Aluminum Hydroxide and CpG 1018TM Adjuvants: The Effect on Stability and Immunogenicity of a Recombinant SARS-CoV-2 RBD Antigen. Volume 11. Vaccines; 2023. p. 1030.","DOI":"10.3390\/vaccines11061030"},{"key":"2175_CR16","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1002\/jps.21143","volume":"97","author":"AL Clausi","year":"2008","unstructured":"Clausi AL, Merkley SA, Carpenter JF, Randolph TW. Inhibition of aggregation of aluminum hydroxide adjuvant during freezing and drying. J Pharm Sci. 2008;97:2049\u201361.","journal-title":"J Pharm Sci"},{"key":"2175_CR17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/jps.21433","volume":"98","author":"AL Clausi","year":"2009","unstructured":"Clausi AL, Morin A, Carpenter JF, Randolph TW. Influence of protein conformation and adjuvant aggregation on the effectiveness of aluminum hydroxide adjuvant in a model alkaline phosphatase vaccine. J Pharm Sci. 2009;98:114\u201321.","journal-title":"J Pharm Sci"},{"key":"2175_CR18","doi-asserted-by":"crossref","unstructured":"Moni SS, Abdelwahab SI, Jabeen A, Elmobark ME, Aqaili D, Gohal G, Oraibi B, Farasani AM, Jerah AA, Alnajai MMA. Advancements in vaccine adjuvants: the journey from alum to nano formulations. Volume 11. Vaccines; 2023. p. 1704.","DOI":"10.3390\/vaccines11111704"},{"key":"2175_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jconrel.2015.02.035","volume":"204","author":"X Li","year":"2015","unstructured":"Li X, Thakkar SG, Ruwona TB, Williams RO III, Cui Z. A method of lyophilizing vaccines containing aluminum salts into a dry powder without causing particle aggregation or decreasing the immunogenicity following reconstitution. J Controlled Release. 2015;204:38\u201350.","journal-title":"J Controlled Release"},{"key":"2175_CR20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/medicines12010004","volume":"12","author":"HX Nguyen","year":"2025","unstructured":"Nguyen HX. Beyond the needle: innovative microneedle-based transdermal vaccination. Medicines. 2025;12:4.","journal-title":"Medicines"},{"key":"2175_CR21","doi-asserted-by":"publisher","first-page":"3414","DOI":"10.1007\/s13346-025-01854-4","volume":"15","author":"S Pahal","year":"2025","unstructured":"Pahal S, Huang F, Singh P, Sharma N, Pham H-P, Tran TBT, Sakhrie A, Akbaba H. Duc Nguyen, Enhancing vaccine stability in transdermal microneedle platforms. Drug Delivery Translational Res. 2025;15:3414\u201338.","journal-title":"Drug Delivery Translational Res"},{"key":"2175_CR22","doi-asserted-by":"publisher","first-page":"114811","DOI":"10.1016\/j.ejpb.2025.114811","volume":"214","author":"JS Kim","year":"2025","unstructured":"Kim JS, Kim N-E, Choi J-a, Choi I-J, Choi J-E, Kang A, Kwon D, Lim M, Kim J, Baek S-K. Powder-attached microneedlesfor the stable and eff ective transdermal delivery of clinically validated mRNA-LNP vaccine. Eur J Pharm Biopharm. 2025;214:114811.","journal-title":"Eur J Pharm Biopharm"},{"key":"2175_CR23","doi-asserted-by":"publisher","first-page":"126906","DOI":"10.1016\/j.ijpharm.2026.126906","volume":"673","author":"S Kim","year":"2026","unstructured":"Kim S, Kim H, Kwon M-J, Ryu M, Kim JS, Baek S-K, Kim C, Lee JM, Kwak K, Park J-H. On-site loading of powder-attached microneedles enables quantitative and reproducible intradermal vaccine delivery. Int J Pharm. 2026;673:126906.","journal-title":"Int J Pharm"},{"key":"2175_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.colsurfa.2008.07.031","volume":"330","author":"L Wolff","year":"2008","unstructured":"Wolff L, Flemming J, Schmitz R, Gr\u00f6ger K, M\u00fcller-Goymann C. Protection of aluminum hydroxide during lyophilisation as an adjuvant for freeze-dried vaccines. Colloids Surf A. 2008;330:116\u201326.","journal-title":"Colloids Surf A"},{"key":"2175_CR25","doi-asserted-by":"crossref","unstructured":"Alzhrani RF, Xu H, Moon C, Suggs LJ, Williams RO III, Cui Z. Thin-film freeze-drying is a viable method to convert vaccines containing aluminum salts from liquid to dry powder. In: Pfeifer BA, Hill A, editors. Vaccine Delivery Technology: Methods and Protocols. New York: Springer; 2020. pp. 489\u201398.","DOI":"10.1007\/978-1-0716-0795-4_27"},{"key":"2175_CR26","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.jconrel.2022.10.003","volume":"351","author":"J-E Choi","year":"2022","unstructured":"Choi J-E, Cha H-R, Kim S, Kim JS, Kim M-J, Chung HW, Baek S-K, Lee JM, Park J-H. Preparation of particle-attached microneedles using a dry coating process. J Controlled Release. 2022;351:1003\u201316.","journal-title":"J Controlled Release"},{"key":"2175_CR27","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0011-2240(88)90032-6","volume":"25","author":"JF Carpenter","year":"1988","unstructured":"Carpenter JF, Crowe JH. The mechanism of cryoprotection of proteins by solutes. Cryobiology. 1988;25:244\u201355.","journal-title":"Cryobiology"},{"key":"2175_CR28","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.vaccine.2003.09.037","volume":"22","author":"A Wittayanukulluk","year":"2004","unstructured":"Wittayanukulluk A, Jiang D, Regnier FE, Hem SL. Effect of microenvironment pH of aluminum hydroxide adjuvant on the chemical stability of adsorbed antigen. Vaccine. 2004;22:1172\u20136.","journal-title":"Vaccine"},{"key":"2175_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10450-010-9243-0","volume":"16","author":"S Chibowski","year":"2010","unstructured":"Chibowski S, Wi\u015bniewska M, Urban T. Influence of solution pH on stability of aluminum oxide suspension in presence of polyacrylic acid. Adsorption. 2010;16:321\u201332.","journal-title":"Adsorption"},{"key":"2175_CR30","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/jfb13010002","volume":"13","author":"I Miranda","year":"2021","unstructured":"Miranda I, Souza A, Sousa P, Ribeiro J, Castanheira EM, Lima R, Minas G. Properties and applications of PDMS for biomedical engineering: A review. J Funct biomaterials. 2021;13:2.","journal-title":"J Funct biomaterials"},{"key":"2175_CR31","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41578-021-00372-2","volume":"7","author":"GA Roth","year":"2022","unstructured":"Roth GA, Picece VC, Ou BS, Luo W, Pulendran B, Appel EA. Designing spatial and temporal control of vaccine responses. Nat Reviews Mater. 2022;7:174\u201395.","journal-title":"Nat Reviews Mater"},{"key":"2175_CR32","doi-asserted-by":"publisher","first-page":"125992","DOI":"10.1016\/j.ijpharm.2025.125992","volume":"683","author":"AM Abraham","year":"2025","unstructured":"Abraham AM, Afolabi OE, Anjani QK, Donnelly RF. PowderInjector microneedles: smart cavity microneedles as a novel intradermal delivery system for high doses of niacinamide. Int J Pharm. 2025;683:125992.","journal-title":"Int J Pharm"},{"key":"2175_CR33","doi-asserted-by":"publisher","first-page":"119733","DOI":"10.1016\/j.biomaterials.2019.119733","volume":"232","author":"S Kim","year":"2020","unstructured":"Kim S, Yang H, Eum J, Ma Y, Lahiji SF, Jung H. Implantable powder-carrying microneedles for transdermal delivery of high-dose insulin with enhanced activity. Biomaterials. 2020;232:119733.","journal-title":"Biomaterials"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02175-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02175-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02175-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T18:53:09Z","timestamp":1782586389000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02175-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":33,"alternative-id":["2175"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02175-w","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All mice were maintained under specific pathogen-free conditions. Animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Yonsei University College of Medicine (approval number: IACUC-2024-0199) and conducted in accordance with the approved ethical guidelines. Female BALB\/c mice (6 weeks old; Orient Bio) were purchased and acclimated for one week prior to experimentation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"PJH and BSK are inventors on patents related to microneedle technologies that have been licensed to companies developing microneedle-based products and are shareholders in such companies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}